Modera Wealth Management LLC Has $1.04 Million Holdings in CME Group Inc. (NASDAQ:CME)

Modera Wealth Management LLC boosted its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 3.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,707 shares of the financial services provider’s stock after acquiring an additional 141 shares during the period. Modera Wealth Management LLC’s holdings in CME Group were worth $1,039,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the company. CVA Family Office LLC lifted its position in shares of CME Group by 11.8% during the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after purchasing an additional 46 shares during the last quarter. Capital Advisors Ltd. LLC increased its position in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after buying an additional 48 shares during the period. Lester Murray Antman dba SimplyRich boosted its position in shares of CME Group by 0.7% in the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after acquiring an additional 50 shares during the period. Essex LLC grew its stake in shares of CME Group by 3.3% in the first quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock worth $355,000 after acquiring an additional 52 shares during the last quarter. Finally, Quent Capital LLC grew its stake in shares of CME Group by 10.2% in the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after acquiring an additional 55 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of CME stock opened at $228.12 on Tuesday. The stock’s fifty day simple moving average is $219.32 and its 200 day simple moving average is $208.98. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36. The firm has a market cap of $82.14 billion, a price-to-earnings ratio of 25.95, a P/E/G ratio of 7.76 and a beta of 0.55. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the business earned $2.25 earnings per share. The business’s revenue was up 18.4% on a year-over-year basis. On average, analysts expect that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a $1.15 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on CME shares. Citigroup upped their target price on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research note on Thursday, October 24th. Piper Sandler upped their price objective on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research report on Monday. Bank of America increased their target price on shares of CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday, October 3rd. Oppenheimer boosted their price target on CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research note on Thursday, October 24th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $222.73.

Read Our Latest Stock Report on CME Group

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.